Genome-scale technologies, analytical tools and unprecedented amount of valuable clinical information drive therapeutic, diagnostic and prognostic advances in cancer medicine.39 Because DR3 and TL1A expression appeared to be important in determining the apoptotic response of cancer cells in our laboratory studies, we sought to expand our finding by mining vast database offered by Oncomine. The gene discussed is TNFRSF25; the disease is cancer.